The United Laboratories International Holdings (HK:3933) has released an update.
The United Laboratories International Holdings has announced that its Cefuroxime Sodium for Injection has passed the consistency evaluation by the China National Medical Products Administration, enhancing its position in the anti-infective market. This antibiotic is widely used for treating various infections and is part of the National Essential Drug List and the National Medical Insurance Drug List. The approval is expected to boost the company’s value and commitment to developing new products.
For further insights into HK:3933 stock, check out TipRanks’ Stock Analysis page.
